Apellis Pharmaceuticals, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
-14.97 | -268.1 | -94.42% | -11.17 | +34.03% |
| P/S |
|
5.06 | 55.96 | -90.96% |
|
|
| P/BV |
|
17.29 | 251.23 | -93.12% |
|
|
| P/FCF |
|
-33.55 | -193.71 | -82.68% |
|
|
| Ev/Ebitda |
|
-25.96 | 12.23 | -312.17% |
|
|
| Ev/S |
|
5.13 | 457.86 | -98.88% |
|
|
| Ev/FCF |
|
-45.44 | -232.19 | -80.43% |
|
|
| E/P |
|
-0.0668 | 0.0158 | -521.51% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-19.78 | -339.51 | -94.17% | -356.75 | -94.46% |
| ROE |
|
-93.55 | 98.24 | -195.23% |
|
|
| ROA |
|
-23.64 | -5.02 | 370.79% |
|
|
| ROIC |
|
-121.89 | 1.2 | -10293.19% |
|
|
| ROS |
|
-25.32 | -298.06 | -91.51% |
|
|
| ROCE |
|
-68.4 | -0.0718 | 95196.36% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-3.04 | 0.9431 | -422.35% | -1.35 | +124.39% |
| Nеt Debt/Ebitda |
|
-0.3785 | 1.03 | -136.92% |
|
|
| Debt/Ratio |
|
0.5308 | 0.1785 | 197.32% |
|
|
| Debt/Equity |
|
2.87 | 1.56 | 84.2% |
|
|
| Debt/Net Income |
|
-2.37 | -1.48 | 60.39% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5195 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.8478 | -100% | ||
| DSI |
|
0 | 0.2116 | -100% |
|
|
| Average dividend growth |
|
0 | 1.31 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4975 | -100% |
|
|
| Average percentage for payments |
|
0 | 58.24 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5195 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
211.8 | -87.95 | -340.82% | ||
| Growth impulse Ebitda in 5 years |
|
-26.2 | -156.19 | -83.23% | ||
| Growth impulse Net Income in 5 years |
|
-42.63 | -172.49 | -75.29% | ||
| Growth impulse FCF in 5 years |
|
-46.79 | -114.63 | -59.18% | ||
| Growth impulse EPS in 5 years |
|
-65.21 | -121.56 | -46.36% |
IP Score
2.69/10
